Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell, Marginal Zone trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 3 Status: Unknown status Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20072
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clatterbridge Centre for Oncology1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Jonsson Comprehensive Cancer Center1
Lymphoma Study Association1
Scotland and Newcastle Lymphoma Group1
St. Bartholomew's Hospital1
Technische Universität Dresden1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma8
Lymphoma, Follicular8
Lymphoma, Non-Hodgkin8
Burkitt Lymphoma6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Large-Cell, Immunoblastic6
Lymphoma, Mantle-Cell6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.